HOME   |    PDF   |   


Title

Serum fetuin A and cystatin B as biomarkers among autism spectrum disorder patients in central India

 

Authors

Sameeksha Luthra1, Niranjan Gopal1, Urmila Dahake2, Dnyanesh Amle1, Jyoti E. John1, Roshan Takhelmayum1, Utsav Haldar1,*, Jancy Jose1 & Chandrasekaran Kirubhanand3

 

Affiliation

1Department of Biochemistry, All India Institute of Medical Sciences, Nagpur, Maharashtra, India; 2Department of Paediatrics, All India Institute of Medical Sciences, Nagpur, Maharashtra, India; 3Department of Anatomy, All India Institute of Medical Sciences, Nagpur, Maharashtra, India; *Corresponding author

 

Email

Urmila Dahake - E-mail: drurmilachauhan@aiimsnagpur.edu.in
Dnyanesh Amle - E-mail: dnyanesh@aiimsnagpur.edu.in
Jyoti E. John - E-mail: jyotijohn@aiimsnagpur.edu.in
Roshan Takhelmayum - E-mail: roshan@aiimsnagpur.edu.in
Utsav Haldar - E-mail: utsavh07@gmail.com
Jancy Jose - E-mail: jancyjose@aiimsnagpur.edu.in
Chandrasekhar Kirubhanand - E-mail: kirubhanand@aiimsnagpur.edu.in

Sameeksha Luthra - E-mail: sameekshaluthra26@gmail.com
Niranjan Gopal - E-mail: niranjang@aiimsnagpur.edu.in

 

Article Type

Research Article

 

Date

Received February 1, 2026; Revised February 28, 2026; Accepted February 28, 2026, Published February 28, 2026

 

Abstract

Autism Spectrum Disorder (ASD) remains underdiagnosed in low- and middle-income countries due to reliance on subjective behavioural assessments and lack of validated objective biomarkers for early detection. Therefore, it is of interest to investigate the potential of two serum biomarkers, Fetuin-A and Cystatin B, as objective diagnostic indicators for ASD in 60 children from Central India (30 with ASD, 30 controls). While Fetuin-A showed a non-significant trend of elevation in the ASD group, Cystatin B levels were found to be significantly elevated in the ASD subjects compared to the neurotypical controls. ROC analysis demonstrated moderate diagnostic potential for both, with Cystatin B showing a higher Area under the Curve (AUC) of 69.5%. Thus, Cystatin B is a promising serum biomarker that could supplement current diagnostic tools for the early and accurate identification of ASD.

 

Keywords

Autism spectrum disorder (ASD); Cystatin B; Fetuin-A; Biomarkers; Neuroinflammation; India; Paediatric Neurodevelopment; Enzyme-Linked Immunosorbent Assay (ELISA); ROC Analysis

 

Citation

Luthra et al. Bioinformation 22(2): 733-738 (2026)

 

Edited by

P Kangueane

 

ISSN

0973-2063

 

Publisher

Biomedical Informatics

 

License

This is an Open Access article which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly credited. This is distributed under the terms of the Creative Commons Attribution License.